Healthcare Sales & Marketing Network News: Mino-Lok

Searching News Database: Mino-Lok

HSMN NewsFeed - 8 Sep 2023
Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR(TM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Jun 2020
Citius Receives FDA Response on Pre-Investigational New Drug (PIND) Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Nov 2019
Citius Pharmaceuticals Issues Corporate Update
Biopharmaceuticals

HSMN NewsFeed - 4 Sep 2019
Citius Announces Change To Primary Endpoint In Mino-Lok(R) Phase 3 Study
Biopharmaceuticals

HSMN NewsFeed - 4 Apr 2019
Citius Pharmaceuticals Successfully Raises $5.3 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Jul 2016
Citius Pharmaceuticals Completes Feasibility Study of Investigator Sites for Mino-Lok(TM) Phase 3 Trials
Biopharmaceuticals

Return to NewsFeed

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!